Who makes Ocrelizumab at home?

Ocrelizumab at home is developed by University of Colorado, Denver.

What development phase is Ocrelizumab at home in?

Ocrelizumab at home is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Ocrelizumab at home

University of Colorado, Denver · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Ocrelizumab at home
Sponsor	University of Colorado, Denver
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Home Based Infusions for Ocrelizumab (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ocrelizumab at home CI brief — competitive landscape report
Ocrelizumab at home updates RSS · CI watch RSS
University of Colorado, Denver portfolio CI